Podoplanin expression in cancer-associated fibroblasts predicts aggressive behavior in melanoma

Journal of Cutaneous Pathology

Volumn 41, Issue 7, 2014, Pages 561-567

  Kan, Saori ^a   Konishi, Eiichi ^a   Arita, Takahiro ^a   Ikemoto, Chika ^a   Takenaka, Hideya ^a   Yanagisawa, Akio ^a   Katoh, Norito ^a   Asai, Jun ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

cancer associated fibroblasts; melanoma; metastasis; podoplanin; prognostic factor

Indexed keywords

MEMBRANE PROTEIN; PDPN PROTEIN, HUMAN; TUMOR PROTEIN;

AGED; BIOSYNTHESIS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; MALE; MELANOMA; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SKIN TUMOR; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84903538242     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12322     Document Type: Article

References (24)

1. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507.
2. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711.
3. Ordonez NG,. Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update. Appl Immunohistochem Mol Morphol 2014; 22: 331.
4. Krishnan H, Ochoa-Alvarez JA, Shen Y, et al. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility. J Biol Chem 2013; 288: 12215.
5. Wicki A, Christofori G,. The potential role of podoplanin in tumour invasion. Br J Cancer 2007; 96: 1.
6. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G,. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006; 9: 261.
7. Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M,. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci 2006; 119: 4541.
8. Hoshino A, Ishii G, Ito T, et al. Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression. Cancer Res 2011; 71: 4769.
9. Schoppmann SF, Berghoff A, Dinhof C, et al. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer. Breast Cancer Res Treat 2012; 134: 237.
10. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199.
11. Kato Y, Kaneko M, Sata M, Fujita N, Tsuruo T, Osawa M,. Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma. Tumour Biol 2005; 26: 195.
12. Kimura N, Kimura I,. Podoplanin as a marker for mesothelioma. Pathol Int 2005; 55: 83.
13. Schacht V, Ramirez MI, Hong YK, et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003; 22: 3546.
14. Bissell MJ, Radisky D,. Putting tumours in context. Nat Rev Cancer 2001; 1: 46.
15. Thiery JP,. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442.
16. Hasebe T, Sasaki S, Imoto S, Ochiai A,. Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast. Am J Pathol 2000; 156: 1701.
17. Kim JB, Stein R, O'Hare MJ,. Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Tumour Biol 2005; 26: 173.
18. Kalluri R, Zeisberg M,. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392.
19. Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L,. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 2001; 61: 1320.
20. Olsen CJ, Moreira J, Lukanidin EM, Ambartsumian NS,. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer 2010; 10: 444.
21. Pula B, Wojnar A, Witkiewicz W, Dziegiel P, Podhorska-Okolow M,. Podoplanin expression in cancer-associated fibroblasts correlates with VEGF-C expression in cancer cells of invasive ductal breast carcinoma. Neoplasma 2013; 60: 516.
22. Massi D, Puig S, Franchi A, et al. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol 2006; 59: 166.
23. Cianfarani F, Mastroeni S, Odorisio T, et al. Expression of vascular endothelial growth factor-C in primary cutaneous melanoma predicts sentinel lymph node positivity. J Cutan Pathol 2012; 39: 826.
24. Shimoda M, Mellody KT, Orimo A,. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 2010; 21: 19.